|
|
|
|
|
|
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期- |
A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults
The purpose of this study is to evaluate the Pharmacokinetics, Safety, Tolerability of Nirsevimab in Healthy Chinese Adults.
100 项与 IQVIA RDS (Shanghai) Co. Ltd. 相关的临床结果
0 项与 IQVIA RDS (Shanghai) Co. Ltd. 相关的专利(医药)
100 项与 IQVIA RDS (Shanghai) Co. Ltd. 相关的药物交易
100 项与 IQVIA RDS (Shanghai) Co. Ltd. 相关的转化医学